To read this content please select one of the options below:

Abstract

It is January 2014, and the case protagonist, David Milestone (senior advisor at the Center for Accelerating Innovation and Impact at the U.S. Agency for International Development's Global Health Bureau), is preparing for a meeting of global stakeholders and pharmaceutical manufacturers who are interested in reducing mortality caused by childhood pneumonia and are prepared to donate $10 million to support this effort.

Milestone's goal is to propose a strategy to address childhood pneumonia in Uganda, toward which the $10 million donation would go. In addition to effectively and sustainably reducing childhood pneumonia deaths, the plan must align the interests of various stakeholders behind the problem. A successful strategy in Uganda could be a model for interventions elsewhere. The United Nations Commission on Lifesaving Commodities for Women and Children recently identified Uganda as a “pathfinder” country, meaning it could serve as the example for other countries wrestling with the same issues. This is a remarkable opportunity to change the lives of children in Uganda—and all around the world.

After reading and analyzing the case, students will be able to:

  • Perform a stakeholder analysis

  • Appreciate the challenges involved in improving public health, especially in developing countries

  • Create a patient journey and use it to identify potential impact points

Keywords

Citation

Calkins, T., Palamountain, K., Chatterjee, A., Frantz, R., Hart, E., Mathewson, S. and Perez-Hobrecker, G. (2017), "Fighting Childhood Pneumonia in Uganda", . https://doi.org/10.1108/case.kellogg.2016.000120

Publisher

:

Kellogg School of Management

Copyright © 2015, The Kellogg School of Management at Northwestern University

Related articles